Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The revision is updated from v3.5.4 to v3.5.5, reflecting a small update to the page's documentation/release notes.
    Difference
    0.0%
    Check dated 2026-06-05T22:42:01.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.5.3 to v3.5.4, indicating a new version of the page framework. This update does not alter the study data or visible content.
    Difference
    0.0%
    Check dated 2026-05-15T14:22:38.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study record now shows Terminated status with participation details and the Informed Consent Form PDF added to the study documents, while the previous Active, not recruiting status was removed.
    Difference
    0.7%
    Check dated 2026-05-01T08:29:21.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now shows an updated site revision/version identifier (from v3.5.2 to v3.5.3), indicating a background update to the ClinicalTrials.gov interface rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:15:32.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:40:40.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Results data were posted, including radiographic RECIST responses, pathologic response, adverse events, and survival outcomes with timing details. The update also references the associated study documents and submission dates.
    Difference
    3%
    Check dated 2026-03-19T05:21:08.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.